Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-10 Sale | 2024-04-10 4:03 pm | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 7,791 | $27.55 | $214,642 | 153,329 (Direct) | View |
2024-01-24 Sale | 2024-01-24 4:22 pm | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 10,722 | $21.64 | $232,024 | 129,253 (Direct) | View |
2024-01-09 Sale | 2024-01-09 4:26 pm | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 8,391 | $22.99 | $192,909 | 116,075 (Direct) | View |
2023-06-30 Sale | 2023-06-30 4:07 pm | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 10,718 | $28.36 | $303,962 | 130,866 (Direct) | View |
2019-11-13 Purchase | 2019-11-15 4:05 pm | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 40,322 | $31 | $1,249,982 | 41,722 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-20 Option Award | 2024-06-24 4:10 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 13,894 | $0 | 13,894 (Direct) | View |
2024-06-13 Exercise | 2024-06-17 5:31 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 3,388 | $0 | 140,784 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 12:16 pm | N/A 2034-06-11 | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 15,347 | $0 | 29,325 (Direct) | View |
2024-04-08 Exercise | 2024-04-10 4:03 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 15,934 | $0 | 153,329 (Direct) | View |
2024-01-20 Exercise | 2024-01-24 4:22 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 23,900 | $0 | 129,253 (Direct) | View |
2024-01-05 Exercise | 2024-01-09 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 17,500 | $0 | 116,075 (Direct) | View |
2023-06-28 Exercise | 2023-06-30 4:07 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 23,900 | $0 | 130,866 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 4:00 pm | N/A 2033-06-13 | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 13,799 | $0 | 25,272 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 4:29 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 22,346 | $0 | 22,346 (Direct) | View |
2023-04-12 Tax Withholding | 2023-04-12 4:17 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 4,731 | $21.35 | 125,651 (Direct) | View |
2023-04-08 Exercise | 2023-04-12 4:17 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 15,933 | $0 | 125,651 (Direct) | View |
2023-02-16 Tax Withholding | 2023-02-16 4:03 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 3,648 | $28.91 | 82,582 (Direct) | View |
2023-02-14 Exercise | 2023-02-16 4:03 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director | 11,333 | $0 | 82,582 (Direct) | View |
2022-12-30 Option Award | 2023-01-04 4:02 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 252 | $80.32 | 11,473 (Direct) | View |
2022-09-30 Option Award | 2022-10-04 4:01 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 291 | $66.64 | 11,221 (Direct) | View |
2022-06-30 Option Award | 2022-07-01 4:01 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 275 | $75.97 | 10,930 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 4:01 pm | N/A 2032-06-14 | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 11,268 | $0 | 19,779 (Direct) | View |
2022-04-08 Option Award | 2022-04-12 4:01 pm | N/A 2032-04-08 | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 217,800 | $0 | 217,800 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 4:00 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 280 | $79.42 | 8,511 (Direct) | View |
2022-02-18 Exercise | 2022-02-23 4:10 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 12,379 | $0 | 87,277 (Direct) | View |
2022-02-22 Tax Withholding | 2022-02-23 4:10 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 3,674 | $29.08 | 87,277 (Direct) | View |
2022-02-14 Exercise | 2022-02-16 5:01 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 11,334 | $0 | 77,525 (Direct) | View |
2022-02-14 Tax Withholding | 2022-02-16 5:01 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 3,505 | $30.5 | 77,525 (Direct) | View |
2021-12-31 Option Award | 2022-01-04 4:16 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 289 | $73.4 | 8,231 (Direct) | View |
2021-09-30 Option Award | 2021-10-04 4:32 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 271 | $68.78 | 7,942 (Direct) | View |
2021-06-30 Option Award | 2021-07-02 07:19 am | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 238 | $84.13 | 7,671 (Direct) | View |
2021-05-26 Option Award | 2021-05-28 07:10 am | N/A 2031-05-25 | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 9,933 | $0 | 15,443 (Direct) | View |
2021-03-31 Option Award | 2021-04-01 5:53 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 251 | $81.27 | 5,510 (Direct) | View |
2021-02-14 Exercise | 2021-02-17 4:13 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 11,333 | $0 | 81,030 (Direct) | View |
2021-02-14 Tax Withholding | 2021-02-17 4:13 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 3,398 | $0 | 81,030 (Direct) | View |
2021-02-10 Option Award | 2021-02-12 4:24 pm | N/A 2031-02-10 | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 163,000 | $0 | 163,000 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 4:51 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 237 | $86.98 | 5,259 (Direct) | View |
2020-09-30 Option Award | 2020-10-01 4:48 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 219 | $89.74 | 5,022 (Direct) | View |
2020-06-30 Option Award | 2020-07-01 6:02 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 202 | $103.97 | 4,803 (Direct) | View |
2020-05-26 Option Award | 2020-05-28 4:18 pm | N/A 2030-05-25 | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 11,796 | $0 | 15,115 (Direct) | View |
2020-04-13 Exercise | 2020-04-15 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 12,379 | $0 | 75,187 (Direct) | View |
2020-04-14 Tax Withholding | 2020-04-15 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 3,673 | $40.64 | 75,187 (Direct) | View |
2020-03-31 Option Award | 2020-04-02 5:18 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 270 | $73.23 | 3,319 (Direct) | View |
2020-03-22 Option Award | 2020-03-24 4:32 pm | N/A N/A | DICK'S SPORTING GOODS INC. | DKS | FOUSE JACQUALYN A Director | 9,518 | $0 | 55,288 (Direct) | View |
2020-02-14 Option Award | 2020-02-19 4:52 pm | N/A 2030-02-14 | AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer | 171,000 | $0 | 171,000 (Direct) | View |
2019-12-31 Option Award | 2020-01-03 4:15 pm | N/A N/A | INCYTE CORP | INCY | FOUSE JACQUALYN A Director | 218 | $87.32 | 3,049 (Direct) | View |